CD44 and cancer: Additionally, in line with the findings of recent studies, which showed that calcium signaling can be a major regulator of cancer stem cell on solid tumors [51, 52], our findings suggest that CASQ2‐overexpressing cells show several surrogate features of cancer stem cells, such as tumorsphere growth and CD44 expression upregulation, which was reversed by lacidipine treatment.